IQVIA carried total debt between $13.4B and $16.2B for nine of the last ten quarters with debt-to-equity consistently above 2.0x, while goodwill of $16.9B accounts for roughly 55% of $30.5B in total assets and the current ratio has remained below 1.0 (ranging 0.70-0.85) throughout — all of which may indicate meaningful impairment sensitivity and tight liquidity, compounded by the highly irregular Q3 2026 collapse in reported debt to $1.5B and D/E to 0.22 that warrants verification.
IQVIA Holdings Inc. (IQV) balance sheet — 15-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|
| Total Current Assets | 6.45B | 6.25B | 5.83B | 5.6B | 4.98B | 4.76B | 5.09B | 4.13B | 3.87B | 3.55B | 3.34B | 2.41B | 2.15B | 1.95B | 1.51B | 1.37B |
| Cash & Short-Term Investments | 2.42B | 2.14B | 1.84B | 1.5B | 1.31B | 1.48B | 1.9B | 899M | 938M | 1B | 1.24B | 977.15M | 867.36M | 778.14M | 567.73M | 516.3M |
| Cash Only | 2.25B | 1.98B | 1.7B | 1.38B | 1.22B | 1.37B | 1.81B | 837M | 891M | 959M | 1.2B | 977.15M | 867.36M | 778.14M | 567.73M | 516.3M |
| Short-Term Investments | 173M | 161M | 141M | 120M | 93M | 111M | 88M | 62M | 47M | 46M | 40M | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 3.33B | 3.43B | 3.24B | 3.41B | 2.96B | 2.61B | 2.47B | 2.64B | 2.46B | 2.14B | 1.74B | 1.2B | 1.02B | 940.38M | 837.05M | 716.49M |
| Days Sales Outstanding | 74.15 | 76.69 | 76.77 | 83.14 | 74.98 | 68.64 | 79.24 | 86.84 | 86.34 | 80.66 | 93.25 | 76.34 | 68.23 | 67.31 | 62.79 | 60.43 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 487M | 519M | 592M | 546M | 561M | 521M | 563M | 451M | 322M | 259M | 235M | 181.89M | 213.49M | 184.37M | 145.94M | 46.71M |
| Total Non-Current Assets | 24.02B | 23.7B | 21.07B | 21.09B | 20.36B | 19.93B | 19.47B | 19.13B | 18.68B | 19.29B | 17.87B | 1.51B | 1.16B | 1.12B | 989.16M | 957.44M |
| Property, Plant & Equipment | 847M | 823M | 773M | 819M | 863M | 903M | 953M | 954M | 434M | 440M | 406M | 188.39M | 190.3M | 199.58M | 194M | 185.77M |
| Fixed Asset Turnover | 20.79x | 19.82x | 19.93x | 18.30x | 16.70x | 15.36x | 11.92x | 11.62x | 23.99x | 22.05x | 16.79x | 30.45x | 28.69x | 25.55x | 25.08x | 23.30x |
| Goodwill | 16.9B | 16.62B | 14.71B | 14.57B | 13.92B | 13.3B | 12.65B | 12.16B | 11.8B | 11.85B | 10.73B | 719.74M | 464.43M | 409.63M | 302.43M | 278.04M |
| Intangible Assets | 4.74B | 4.96B | 4.5B | 4.84B | 4.82B | 4.94B | 5.21B | 5.51B | 5.95B | 6.59B | 6.39B | 368.11M | 280.24M | 298.05M | 272.81M | 269.41M |
| Long-Term Investments | 1.52B | 432M | 374M | 239M | 162M | 164M | 162M | 152M | 142M | 78M | 82M | 85.29M | 66.01M | 63.28M | 55.1M | 33.89M |
| Other Non-Current Assets | 606M | 505M | 520M | 455M | 472M | 491M | 386M | 227M | 239M | 235M | 177M | 110.11M | 122.79M | 117.71M | 127.51M | 112.15M |
| Total Assets | 30.47B | 29.94B | 26.9B | 26.68B | 25.34B | 24.69B | 24.56B | 23.25B | 22.55B | 22.74B | 21.21B | 3.93B | 3.31B | 3.07B | 2.5B | 2.32B |
| Asset Turnover | 0.58x | 0.54x | 0.57x | 0.56x | 0.57x | 0.56x | 0.46x | 0.48x | 0.46x | 0.43x | 0.32x | 1.46x | 1.65x | 1.66x | 1.95x | 1.86x |
| Asset Growth % | 30.38% | 11.32% | 0.82% | 5.3% | 2.62% | 0.51% | 5.65% | 3.11% | -0.85% | 7.23% | 440.15% | 18.77% | 7.79% | 22.71% | 7.59% | - |
| Total Current Liabilities | 7.78B | 8.34B | 6.96B | 6.49B | 5.58B | 5.24B | 4.56B | 3.94B | 3.53B | 2.9B | 2.71B | 1.59B | 1.47B | 1.48B | 1.32B | 1.19B |
| Accounts Payable | 3.68B | 3.75B | 736M | 709M | 645M | 621M | 581M | 2.51B | 437M | 322M | 250M | 145.48M | 108.74M | 100.62M | 84.71M | 70.03M |
| Days Payables Outstanding | 105.18 | 125.84 | 26.78 | 26.56 | 25.09 | 24.55 | 28.28 | 125.6 | 23.64 | 18.65 | 19.22 | 12.9 | 10.03 | 9.76 | 8.51 | 8.02 |
| Short-Term Debt | 1.24B | 1.84B | 1.15B | 718M | 152M | 91M | 149M | 100M | 100M | 103M | 92M | 48.51M | 826K | 10.43M | 55.71M | 20.15M |
| Deferred Revenue (Current) | 6.86B | 2.12B | 1.78B | 1.8B | 1.8B | 1.82B | 1.25B | 1.01B | 1.01B | 733M | 774M | 584.65M | 543.3M | 538.59M | 456.59M | 398.47M |
| Other Current Liabilities | 544M | 489M | 1.1B | 1.26B | 1.13B | 1.15B | 1.09B | 211M | -1.17B | 666M | 630M | 420M | 432.94M | 472.78M | 404.88M | 362.71M |
| Current Ratio | 0.83x | 0.75x | 0.84x | 0.86x | 0.89x | 0.91x | 1.12x | 1.05x | 1.10x | 1.22x | 1.23x | 1.51x | 1.46x | 1.31x | 1.15x | 1.15x |
| Quick Ratio | 0.83x | 0.75x | 0.84x | 0.86x | 0.89x | 0.91x | 1.12x | 1.05x | 1.10x | 1.22x | 1.23x | 1.51x | 1.46x | 1.31x | 1.15x | 1.15x |
| Cash Conversion Cycle | -31.03 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 15.91B | 14.98B | 13.88B | 14.08B | 13.99B | 13.41B | 13.73B | 13.04B | 12.06B | 11.48B | 9.64B | 2.67B | 2.54B | 2.25B | 2.54B | 2.1B |
| Long-Term Debt | 14.82B | 14.11B | 12.84B | 12.96B | 12.6B | 12.03B | 12.38B | 11.54B | 10.91B | 10.12B | 7.11B | 2.42B | 2.28B | 2.04B | 2.37B | 1.95B |
| Capital Lease Obligations | 946M | 225M | 173M | 223M | 264M | 313M | 371M | 396M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 668M | 179M | 196M | 202M | 464M | 410M | 338M | 646M | 736M | 918M | 2.13B | 65.7M | 61.8M | 37.54M | 11.62M | 9.87M |
| Other Non-Current Liabilities | 679M | 463M | 668M | 698M | 671M | 649M | 633M | 456M | 418M | 440M | 402M | 183M | 183.66M | 178.91M | 171.32M | 138.81M |
| Total Liabilities | 23.68B | 23.31B | 20.83B | 20.57B | 19.57B | 18.65B | 18.28B | 16.99B | 15.6B | 14.38B | 12.35B | 4.26B | 4.01B | 3.73B | 3.86B | 3.29B |
| Total Debt | 16.31B | 16.17B | 14.16B | 13.9B | 13.01B | 12.44B | 12.9B | 12.04B | 11.01B | 10.22B | 7.2B | 2.47B | 2.29B | 2.05B | 2.42B | 1.97B |
| Net Debt | 14.06B | 14.19B | 12.45B | 12.52B | 11.79B | 11.07B | 11.09B | 11.2B | 10.12B | 9.27B | 6B | 1.49B | 1.43B | 1.27B | 1.85B | 1.46B |
| Debt / Equity | 2.40x | 2.44x | 2.33x | 2.27x | 2.26x | 2.06x | 2.05x | 1.92x | 1.58x | 1.22x | 0.81x | - | - | - | - | - |
| Debt / EBITDA | 4.61x | 5.73x | 4.27x | 4.48x | 4.44x | 4.68x | 6.39x | 6.08x | 5.85x | 5.91x | 7.73x | 3.19x | 3.22x | 3.59x | 4.90x | 4.51x |
| Net Debt / EBITDA | 3.97x | 5.03x | 3.76x | 4.04x | 4.03x | 4.17x | 5.50x | 5.66x | 5.38x | 5.36x | 6.45x | 1.93x | 2.00x | 2.22x | 3.75x | 3.33x |
| Interest Coverage | 3.03x | 3.15x | 3.49x | 3.17x | 4.28x | 4.01x | 1.90x | 1.79x | 1.79x | 1.85x | 3.89x | 6.29x | 5.98x | 3.62x | 2.99x | 2.69x |
| Total Equity | 6.79B | 6.63B | 6.07B | 6.11B | 5.76B | 6.04B | 6.28B | 6.26B | 6.95B | 8.36B | 8.86B | -107.14M | -703.96M | -667.49M | -1.36B | -969.6M |
| Equity Growth % | 32.26% | 9.28% | -0.74% | 6.02% | -4.58% | -3.79% | 0.27% | -9.94% | -16.8% | -5.67% | 8369.17% | 84.78% | -5.46% | 50.89% | -40.17% | - |
| Book Value per Share | 40.66 | 38.21 | 33.08 | 32.81 | 30.25 | 30.98 | 32.21 | 31.38 | 33.40 | 37.55 | 58.29 | -0.85 | -5.37 | -5.22 | -10.65 | -7.60 |
| Total Shareholders' Equity | 6.66B | 6.5B | 6.07B | 6.11B | 5.76B | 6.04B | 6B | 6B | 6.71B | 8.11B | 8.63B | -335.68M | -704.01M | -667.41M | -1.36B | -970.38M |
| Common Stock | 11.58B | 11.38B | 3M | 3M | 10.9B | 3M | 3M | 11.05B | 10.9B | 10.78B | 10.6B | 8.78M | 143.83M | 478.14M | 4.55M | 1.16M |
| Retained Earnings | 8.3B | 7.42B | 6.07B | 4.69B | 3.33B | 2.24B | 1.28B | 998M | 807M | 655M | -399M | -461.63M | -788.8M | -1.15B | -1.37B | -994.41M |
| Treasury Stock | -12.31B | -11.36B | -10.1B | -8.74B | -7.74B | -6.57B | -6.17B | -5.73B | -4.77B | -3.37B | -1B | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -906M | -943M | -1.04B | -867M | -727M | -406M | -205M | -311M | -224M | 46M | -570M | -111.37M | -59.09M | -376K | 7.7M | 22.87M |
| Minority Interest | 131M | 127M | 0 | 0 | 0 | 0 | 279M | 260M | 240M | 249M | 227M | 228.54M | 49K | -72K | 479K | 788K |
Quick answers to the most common questions about buying IQV stock.
As of 2025, IQVIA Holdings Inc. (IQV) had total assets of $29.94B including $6.25B in current assets.
IQVIA Holdings Inc. (IQV) carries total debt of $16.17B, offset by $2.14B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
IQVIA Holdings Inc. (IQV) has total shareholders' equity (book value) of $6.50B ($38.21 book value per share). Book value represents the net worth of the company belonging to common stock holders.
IQVIA Holdings Inc. (IQV) reported a current ratio of 0.75x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage and goodwill impairment concentration
Metrics are mathematically derived from official filings.
Asset Growth Driven by Goodwill Accumulation
IQVIA's total assets expanded 15.5% from $26.4B in Q2 2024 to $30.5B in Q3 2026, yet goodwill alone accounted for $2.4B of that increase, suggesting inorganic growth rather than organic asset accretion. According to IQVIA's reported balance sheets, retained earnings grew $3.0B over the same period.
The steady climb in retained earnings from $5.3B to $8.3B signals genuine profitability accumulation, but total equity fluctuated between $5.8B and $7.0B across the period, implying share repurchases and other equity charges offset a meaningful portion of that retention. This pattern suggests the balance sheet is expanding on the asset side while the equity base remains constrained by aggressive capital return activity, consistent with the buyback-heavy deployment profile observed in cash flow statements.
Leverage Persists Above 2.0x Despite Cash Generation
IQVIA carried total debt between $13.4B and $16.2B for nine of the last ten quarters, with debt-to-equity ratios consistently above 2.0x through Q2 2026. As reported in recent SEC filings, this sustained leverage constrains balance sheet flexibility despite robust operating cash flow generation.
The leverage appears largely legacy-driven from the transformative IMS Health–Quintiles merger rather than necessity-driven, as the company has generated substantial free cash flow yet directed it toward buybacks and acquisitions rather than meaningful debt reduction. The apparent single-quarter collapse in total debt to $1.5B in Q3 2026 is highly anomalous and may represent a data discrepancy rather than actual deleveraging, warranting verification against the company's latest 10-Q filing before any reassessment of the risk profile.
Goodwill Dominates an Asset-Light Balance Sheet
Goodwill of $16.9B represents approximately 55% of IQVIA's $30.5B total assets as of Q3 2026, while net property, plant, and equipment comprises less than 3% at $847M. Based on IQVIA's reported balance sheets, this concentration signals an acquisition-driven asset base with significant impairment sensitivity.
The minimal PPE base confirms IQVIA operates an asset-light services model where human capital and proprietary data drive value, but the sustained goodwill accumulation from $14.5B to $16.9B in under two years suggests continued M&A activity that investors should evaluate for integration returns. Should biotech funding conditions deteriorate or the proprietary data moat face erosion from alternative real-world evidence aggregators, this goodwill concentration creates meaningful impairment risk that could materially compress reported equity and further strain the already elevated leverage ratios.
Sub-Par Current Ratio Signals Tight Working Capital
IQVIA's current ratio has remained below 1.0 for all ten reported quarters, ranging from 0.70 to 0.85, while cash holdings fluctuated between $1.5B and $2.2B against $15B-plus in total debt. According to IQVIA's quarterly financial disclosures, this persistent sub-par ratio warrants close monitoring.
A current ratio consistently below 1.0 may indicate that IQVIA manages working capital aggressively, potentially leaning on supplier financing or deferred payment terms to fund operations rather than maintaining a conventional liquidity buffer. While deferred revenue (when reported at $1.8B–$2.3B) represents unearned customer cash that partially offsets near-term obligations, the combination of sub-par liquidity, $15B-plus in debt, and a buyback program that consumed roughly $4.5B over ten quarters leaves limited shock absorption capacity if operating cash flow were to weaken.
Anomalous Debt Collapse Undermines Leverage Read
The Q3 2026 balance sheet shows total debt plunging from $16.2B to $1.5B with D/E falling from 2.58 to 0.22—a 91% single-quarter decline that appears highly irregular. Per IQVIA's most recent reported figures, this discrepancy against nine prior periods of elevated leverage warrants immediate verification before any risk reassessment.
This anomaly is compounded by deferred revenue dropping from $2.3B to $0 in the same quarter, which could suggest either a data reporting gap or a genuine balance sheet restructuring event that has not yet been publicly explained. If the debt reduction is real, it would fundamentally alter the risk profile and contradict the previously observed net debt/EBITDA of approximately 4.9x; however, if it reflects incomplete data, investors should continue treating IQVIA as a highly levered entity whose balance sheet signal remains strained until confirmed against the 10-Q filing.